Ambeed.cn

首页 / 抑制剂/激动剂 / G蛋白偶联受体/G蛋白 / CRF receptor / Pexacerfont

Pexacerfont {[allProObj[0].p_purity_real_show]}

货号:A1166938 同义名: BMS-562086;DPC-A69448

Pexacerfont is a potent and selective antagonist with IC50 value of 6.1nM.

Pexacerfont 化学结构 CAS号:459856-18-9
Pexacerfont 化学结构
CAS号:459856-18-9
Pexacerfont 3D分子结构
CAS号:459856-18-9
Pexacerfont 化学结构 CAS号:459856-18-9
Pexacerfont 3D分子结构 CAS号:459856-18-9
规格 价格 会员价 库存 数量
{[ item.pr_size ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}

{[ getRatePrice(item.pr_rmb, 1,1) ]}

{[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]}
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} 现货 咨询 - +
购物车0 收藏 询单

Pexacerfont 纯度/质量文件 产品仅供科研

货号:A1166938 标准纯度: {[allProObj[0].p_purity_real_show]}
批次查询: 批次纯度:

全球学术期刊中引用的产品

Cell Host Microbe, 2024. Ambeed. [ A163338 ]
Cancer Res., 2024. Ambeed. [ A295334 ]
J. Pharm. Investig., 2024. Ambeed. [ A221527 , A691302 , A272538 , A187261 ]
J. Fungi, 2024, 10(11): 751. Ambeed. [ A796919 ]
JBC, 2024, 107935. Ambeed. [ A194396 ]
更多 >

Pexacerfont 生物活性

描述 Corticotropin-releasing factor subtype 1 (CRF1) receptor mediates stress-induced activation of the hypothalamic-pituitary-adrenal axis. Pexacerfont is a selective antagonist of CRF1 receptor with IC50 of 6.1 ± 0.6 nM for human CRF1 receptor. Pexacerfont was orally bioavailable in rats, dogs, and chimpanzees, with an absolute oral bioavailability of 40.1, 58.8, and 58.5%, respectively. Pexacerfont had an estimated hepaticextraction ratio of 0.32, 0.38, and 0.08 in rats, dogs, and chimpanzees, respectively. The average Vz of pexacerfont in the rats, dogs, andchimpanzee was 14.9, 28.2, and 4.2 l/kg, respectively. The terminal plasma elimination t1/2 values ranged from 13 to 43 h in rats, dogs, and chimpanzees. After oral administration, peak plasma concentrations (Tmax) of pexacerfont were achieved in less than 2 h for all three species, indicating a rapid oral absorption. Virtual clinical trials performed with a population-based ADME simulator suggested that a minimal dose of 100 mg daily would provide sufficient drug exposure to achieve plasma concentrations above the projected human efficacious plasma concentration of pexacerfont (> 500 nM)[1].

Pexacerfont 参考文献

[1]Zhou L, Dockens RC, Liu-Kreyche P, Grossman SJ, Iyer RA. In vitro and in vivo metabolism and pharmacokinetics of BMS-562086, a potent and orally bioavailable corticotropin-releasing factor-1 receptor antagonist. Drug Metab Dispos. 2012;40(6):1093-1103

Pexacerfont 实验方案

计算器
存储液制备 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.94mL

0.59mL

0.29mL

14.69mL

2.94mL

1.47mL

29.38mL

5.88mL

2.94mL

Pexacerfont 技术信息

CAS号459856-18-9
分子式C18H24N6O
分子量 340.423
别名 BMS-562086;DPC-A69448
运输蓝冰
存储条件

液体 -20°C:3-6个月-80°C:12个月

粉末 Keep in dark place,Sealed in dry,2-8°C

溶解度

DMSO: 50 mg/mL(146.88 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO

动物实验配方
Ambeed 相关网站 Ambeed.cn Ambeed.com
Ambeed
关于我们
联系我们
资讯中心
网站地图
产品手册
  • 批次文件查询
  • 客户支持
    技术支持
    专业术语
    缩略词释义
    质量手册
    产品咨询
    计算器
    活动政策
    订购方法
    积分商城
    活动声明
    联系我们
    400-920-2911 sales@ambeed.cn tech@ambeed.cn
    Ambeed 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务,不为任何个人或者非科研性质用途提供服务。